Citalopram

Product NDC: 65862-005
11-digit product format: 658620005
Labeler code: 65862
Product ID: 65862-005_5642ea11-17b4-431a-a896-2cb336929100
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Citalopram Hydrobromide
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA077031
Marketing category: ANDA
Marketing start: 2004-10-28
Substance: CITALOPRAM HYDROBROMIDE
Active strength: 10 mg/1
Pharmacologic classes: Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
unfinished product	product	65862-005		UNFINISHED	Active or certified unfinished drug listing	2026-08-12
unfinished package	package	65862-005	65862-005-29	UNFINISHED	Active or certified unfinished drug listing	2026-08-12
unfinished package	package	65862-005	65862-005-34	UNFINISHED	Active or certified unfinished drug listing	2026-08-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 63 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	unfinished product	product		`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	65862-005-34	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	65862-005-29	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished product	product		`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	65862-005-34	`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	65862-005-29	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished product	product		`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	65862-005-34	`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	65862-005-29	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished product	product		`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	65862-005-34	`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	65862-005-29	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished product	product		`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	65862-005-34	`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	65862-005-29	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished product	product		`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	65862-005-34	`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	65862-005-29	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished product	product		`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	65862-005-34	`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	65862-005-29	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished product	product		`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	65862-005-34	`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	65862-005-29	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished product	product		`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	65862-005-34	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	65862-005-29	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished product	product		`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	65862-005-34	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	65862-005-29	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished product	product		`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	65862-005-34	`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	65862-005-29	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished product	product		`8d62ce987f31…`	`9fe9ef23e30d…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished package	package	65862-005-34	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished package	package	65862-005-29	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished product	product		`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished package	package	65862-005-34	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished package	package	65862-005-29	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished product	product		`50b4072663b7…`	`eae3003ed65e…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished package	package	65862-005-34	`50b4072663b7…`	`eae3003ed65e…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished package	package	65862-005-29	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished product	product		`906f6e251498…`	`bf70b80e44f0…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished package	package	65862-005-34	`906f6e251498…`	`bf70b80e44f0…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished package	package	65862-005-29	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished product	product		`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	65862-005-34	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	65862-005-29	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished product	product		`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	65862-005-34	`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	65862-005-29	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished product	product		`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	65862-005-34	`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	65862-005-29	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished product	product		`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	65862-005-34	`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	65862-005-29	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished product	product		`263afe128892…`	`91768de4ddbe…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished package	package	65862-005-29	`263afe128892…`	`91768de4ddbe…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished package	package	65862-005-34	`263afe128892…`	`91768de4ddbe…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A077031-001	CITALOPRAM HYDROBROMIDE	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28
A077031-002	CITALOPRAM HYDROBROMIDE	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28
A077031-003	CITALOPRAM HYDROBROMIDE	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A077031-001	AB
A077031-002	AB
A077031-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077031-002	CITALOPRAM HYDROBROMIDE	EQ 20MG BASE	TABLET / ORAL	AB	2004-10-28	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077031-003	CITALOPRAM HYDROBROMIDE	EQ 40MG BASE	TABLET / ORAL	AB	2004-10-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077031-001	CITALOPRAM HYDROBROMIDE	EQ 10MG BASE	TABLET / ORAL	AB	2004-10-28	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077031-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077031-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077031-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077031-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077031-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077031-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077031-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077031-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077031-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077031-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077031-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077031-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077031-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077031-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077031-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077031-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077031-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077031-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077031-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077031-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077031-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077031-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077031-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077031-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077031-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077031-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077031-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077031-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077031-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077031-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077031-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077031-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077031-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077031-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077031-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077031-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077031-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077031-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077031-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077031-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Citalopram
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CITALOPRAM HYDROBROMIDE	10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
I1E9D14F36	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
200371	Internal RxNorm lookup
283672	Internal RxNorm lookup
309314	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2632b547-2e13-447f-ac85-c774e437d6a8	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
475812f9-1b2c-4cb0-9e72-1e52f935ae6f	Product name	1	20221114
0b05d650-9b7b-4b36-a6f4-1a850d5a2e64	Product name	1	20151228
e61ea6cb-0b08-40a9-a984-7b23201c7aa2	Product name	1	20151222

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
65862-005-01	Citalopram	100 in 1 BOTTLE	TABLET, FILM COATED	100	24
65862-005-05	Citalopram	500 in 1 BOTTLE	TABLET, FILM COATED	500	24
65862-005-10	Citalopram	10 in 1 CARTON	TABLET, FILM COATED	10	24
65862-005-10	Citalopram	10 in 1 BLISTER PACK	TABLET, FILM COATED	10	24
65862-005-30	Citalopram	30 in 1 BOTTLE	TABLET, FILM COATED	30	24
65862-005-32	Citalopram	30 in 1 BLISTER PACK	TABLET, FILM COATED	30	24
65862-005-60	Citalopram	60 in 1 BOTTLE	TABLET, FILM COATED	60	24
65862-005-90	Citalopram	90 in 1 BOTTLE	TABLET, FILM COATED	90	24

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-005-01	EA - Each	65862-005	78753051-ab86-4f5c-96f9-4b44587f75c9	1	2012-07-24
65862-005-05	EA - Each	65862-005	d480ed29-4796-4efd-8288-337c9a55f329	1	2012-07-24
65862-005-30	EA - Each	65862-005	0cccea25-7050-4fd7-860f-ec7f8d28b8ad	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CITALOPRAM HYDROBROMIDE	ACTIVE INGREDIENT	I1E9D14F36	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
CITALOPRAM	ACTIVE MOIETY	0DHU5B8D6V	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
COPOVIDONE K25-31	INACTIVE INGREDIENT	D9C330MD8B	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	13
CHOLINE	ACTIVE INGREDIENT	N91BDP6H0X	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
CITALOPRAM HYDROBROMIDE	ACTIVE INGREDIENT	I1E9D14F36	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
CHOLINE	ACTIVE MOIETY	N91BDP6H0X	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
CITALOPRAM	ACTIVE MOIETY	0DHU5B8D6V	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
COPOVIDONE	INACTIVE INGREDIENT	D9C330MD8B	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
GELATIN	INACTIVE INGREDIENT	2G86QN327L	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SENTRALOPRAM AM-10 (CITALOPRAM HYDROBROMIDE, CHOLINE) KIT [PHYSICIAN THERAPEUTICS LLC]	9
CITALOPRAM HYDROBROMIDE	ACTIVE INGREDIENT	I1E9D14F36	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
CITALOPRAM HYDROBROMIDE	ACTIVE INGREDIENT	I1E9D14F36	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
CITALOPRAM	ACTIVE MOIETY	0DHU5B8D6V	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
CITALOPRAM	ACTIVE MOIETY	0DHU5B8D6V	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
COPOVIDONE	INACTIVE INGREDIENT	D9C330MD8B	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
COPOVIDONE K25-31	INACTIVE INGREDIENT	D9C330MD8B	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65862-005	CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	24	Current NDC, Legacy NDC, 8 package rows	20240630_2632b547-2e13-447f-ac85-c774e437d6a8.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 19 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Citalopram	CITALOPRAM HYDROBROMIDE	REMEDYREPACK INC.	625a78b2-4751-4ca5-91b6-7c85fd9f8c2e	2026-03-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	Northwind Health Company, LLC	d9cc1649-913d-832d-e053-2995a90a5f9a	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	Northwind Health Company, LLC	d9ccb3fb-b607-9491-e053-2995a90a39c9	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	QPharma, Inc.	0a967468-3869-4c8c-849f-9fc3a8dcc489	2025-12-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	PD-Rx Pharmaceuticals, Inc.	31a18cdf-b0aa-18f5-e054-00144ff8d46c	2025-10-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	NuCare Pharmaceuticals,Inc.	544ba802-a536-579a-e054-00144ff88e88	2025-06-26	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	Bryant Ranch Prepack	0bc0e09e-0f1d-4d52-b8fe-3ef8a2e5ea52	2025-06-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	REMEDYREPACK INC.	0109f365-bebd-4810-a56f-4451e10245db	2025-04-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram Hydrobromide	CITALOPRAM HYDROBROMIDE	Advanced Rx Pharmacy of Tennessee, LLC	f8b06b55-f6a2-2438-e053-6394a90a530a	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	A-S Medication Solutions	2500cc9d-a67d-46c5-9a76-99bc63959d67	2024-10-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	A-S Medication Solutions	b244d4eb-8311-4663-8bca-dc08e88e5f5d	2024-08-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	QUALLENT PHARMACEUTICALS HEALTH LLC	e0822069-9672-4d4c-bc1a-8739b0dd045c	2024-07-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	Aurobindo Pharma Limited	2632b547-2e13-447f-ac85-c774e437d6a8	2024-05-17	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031 ndc (product): 65862-005
Citalopram	CITALOPRAM HYDROBROMIDE	A-S Medication Solutions	fc766b76-18c1-42cd-b276-f720f5821c11	2024-04-25	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	A-S Medication Solutions	c6730edc-7226-4521-a04a-1bf296b01b8d	2024-02-13	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	NCS HealthCare of KY, LLC dba Vangard Labs	fd761647-e16b-45b3-a4bc-364de0ed7015	2023-09-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	Proficient Rx LP	f37cc307-8b7d-4e5c-8beb-cd8779bc86a7	2022-04-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	Aphena Pharma Solutions - Tennessee, LLC	31ddd184-7560-473c-b674-5fa3187c5598	2020-04-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031
Citalopram	CITALOPRAM HYDROBROMIDE	Proficient Rx LP	289c1d5e-902f-47db-85b8-5e1a55ec8684	2019-11-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077031 application number: ANDA077031

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
I1E9D14F36	CITALOPRAM HYDROBROMIDE	59729-32-7	CITALOPRAM HYDROBROMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
283672	citalopram 10 MG Oral Tablet	PSN	2632b547-2e13-447f-ac85-c774e437d6a8	24
200371	citalopram 20 MG Oral Tablet	PSN	2632b547-2e13-447f-ac85-c774e437d6a8	24
309314	citalopram 40 MG Oral Tablet	PSN	2632b547-2e13-447f-ac85-c774e437d6a8	24
283672	citalopram 10 MG Oral Tablet	SCD	2632b547-2e13-447f-ac85-c774e437d6a8	24
200371	citalopram 20 MG Oral Tablet	SCD	2632b547-2e13-447f-ac85-c774e437d6a8	24
309314	citalopram 40 MG Oral Tablet	SCD	2632b547-2e13-447f-ac85-c774e437d6a8	24
283672	citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet	SY	2632b547-2e13-447f-ac85-c774e437d6a8	24
200371	citalopram 20 MG (as citalopram HBr 24.99 MG) Oral Tablet	SY	2632b547-2e13-447f-ac85-c774e437d6a8	24
309314	citalopram 40 MG (as citalopram HBr 49.98 MG) Oral Tablet	SY	2632b547-2e13-447f-ac85-c774e437d6a8	24
283672	citalopram 10 MG Oral Tablet	PSN	2500cc9d-a67d-46c5-9a76-99bc63959d67	11
283672	citalopram 10 MG Oral Tablet	SCD	2500cc9d-a67d-46c5-9a76-99bc63959d67	11
283672	citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet	SY	2500cc9d-a67d-46c5-9a76-99bc63959d67	11
283672	citalopram 10 MG Oral Tablet	PSN	fd761647-e16b-45b3-a4bc-364de0ed7015	9
283672	citalopram 10 MG Oral Tablet	PSN	b0e39608-a7ed-464a-91c9-867ad7cd293c	9
200371	citalopram 20 MG Oral Tablet	PSN	fd761647-e16b-45b3-a4bc-364de0ed7015	9
309314	citalopram 40 MG Oral Tablet	PSN	fd761647-e16b-45b3-a4bc-364de0ed7015	9
283672	citalopram 10 MG Oral Tablet	SCD	fd761647-e16b-45b3-a4bc-364de0ed7015	9
283672	citalopram 10 MG Oral Tablet	SCD	b0e39608-a7ed-464a-91c9-867ad7cd293c	9
200371	citalopram 20 MG Oral Tablet	SCD	fd761647-e16b-45b3-a4bc-364de0ed7015	9
309314	citalopram 40 MG Oral Tablet	SCD	fd761647-e16b-45b3-a4bc-364de0ed7015	9
283672	citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet	SY	fd761647-e16b-45b3-a4bc-364de0ed7015	9
283672	citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet	SY	b0e39608-a7ed-464a-91c9-867ad7cd293c	9
200371	citalopram 20 MG (as citalopram HBr 24.99 MG) Oral Tablet	SY	fd761647-e16b-45b3-a4bc-364de0ed7015	9
309314	citalopram 40 MG (as citalopram HBr 49.98 MG) Oral Tablet	SY	fd761647-e16b-45b3-a4bc-364de0ed7015	9
283672	citalopram 10 MG Oral Tablet	PSN	d9cc1649-913d-832d-e053-2995a90a5f9a	4
283672	citalopram 10 MG Oral Tablet	SCD	d9cc1649-913d-832d-e053-2995a90a5f9a	4
283672	citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet	SY	d9cc1649-913d-832d-e053-2995a90a5f9a	4
283672	citalopram 10 MG Oral Tablet	PSN	5caff592-a90f-420d-a6ec-9b2dc914529e	2
283672	citalopram 10 MG Oral Tablet	PSN	f8b06b55-f6a2-2438-e053-6394a90a530a	2
200371	citalopram 20 MG Oral Tablet	PSN	5caff592-a90f-420d-a6ec-9b2dc914529e	2
309314	citalopram 40 MG Oral Tablet	PSN	5caff592-a90f-420d-a6ec-9b2dc914529e	2
283672	citalopram 10 MG Oral Tablet	SCD	f8b06b55-f6a2-2438-e053-6394a90a530a	2
283672	citalopram 10 MG Oral Tablet	SCD	5caff592-a90f-420d-a6ec-9b2dc914529e	2
200371	citalopram 20 MG Oral Tablet	SCD	5caff592-a90f-420d-a6ec-9b2dc914529e	2
309314	citalopram 40 MG Oral Tablet	SCD	5caff592-a90f-420d-a6ec-9b2dc914529e	2
283672	citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet	SY	f8b06b55-f6a2-2438-e053-6394a90a530a	2
283672	citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet	SY	5caff592-a90f-420d-a6ec-9b2dc914529e	2
200371	citalopram 20 MG (as citalopram HBr 24.99 MG) Oral Tablet	SY	5caff592-a90f-420d-a6ec-9b2dc914529e	2
309314	citalopram 40 MG (as citalopram HBr 49.98 MG) Oral Tablet	SY	5caff592-a90f-420d-a6ec-9b2dc914529e	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
65862-005-01	65862000501	100 TABLET, FILM COATED in 1 BOTTLE (65862-005-01)		2004-10-28	0000-00-00	No	No	Current
65862-005-05	65862000505	500 TABLET, FILM COATED in 1 BOTTLE (65862-005-05)		2004-10-28	0000-00-00	No	No	Current
65862-005-10	65862000510	10 BLISTER PACK in 1 CARTON (65862-005-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK	10 blister pack	2004-10-28	0000-00-00	No	No	Current
65862-005-29	65862000529	20000 TABLET, FILM COATED in 1 BAG (65862-005-29)		28-OCT-04				Current
65862-005-30	65862000530	30 TABLET, FILM COATED in 1 BOTTLE (65862-005-30)		2004-10-28	0000-00-00	No	No	Current
65862-005-32	65862000532	30 TABLET, FILM COATED in 1 BLISTER PACK (65862-005-32)		2004-10-28	0000-00-00	No	No	Current
65862-005-34	65862000534	24000 TABLET, FILM COATED in 1 BAG (65862-005-34)		28-OCT-04				Current
65862-005-60	65862000560	60 TABLET, FILM COATED in 1 BOTTLE (65862-005-60)		2004-10-28	0000-00-00	No	No	Current
65862-005-90	65862000590	90 TABLET, FILM COATED in 1 BOTTLE (65862-005-90)		2004-10-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Citalopram	Northwind Health Company, LLC	2026-01-01	HUMAN PRESCRIPTION DRUG LABEL	4
Citalopram Hydrobromide Tablets	Advanced Rx Pharmacy of Tennessee, LLC	2024-12-31	HUMAN PRESCRIPTION DRUG LABEL	2
Citalopram	A-S Medication Solutions	2024-10-30	Human Prescription Drug Label	11
Citalopram	Aurobindo Pharma Limited	2024-05-17	Human Prescription Drug Label	24
Citalopram Tablets, USP 10 mg, 20 mg, and 40 mg Rx only	NCS HealthCare of KY, LLC dba Vangard Labs	2023-09-07	HUMAN PRESCRIPTION DRUG LABEL	9
Citalopram	American Health Packaging	2023-02-06	HUMAN PRESCRIPTION DRUG LABEL	10
Citalopram	Bryant Ranch Prepack	2022-05-02	HUMAN PRESCRIPTION DRUG LABEL	6
Citalopram Tablets, USP 10 mg, 20 mg, and 40 mg Rx only	NuCare Pharmaceuticals,Inc.	2021-04-21	HUMAN PRESCRIPTION DRUG LABEL	3
Citalopram Tablets, USP 10 mg, 20 mg, and 40 mg Rx only	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	2020-09-14	HUMAN PRESCRIPTION DRUG LABEL	2
Citalopram Tablets, USP	Lake Erie Medical DBA Quality Care Products LLC	2019-10-17	Human Prescription Drug Label	4
Citalopram Tablets, USP	NuCare Pharmaceuticals, Inc.	2017-03-10	HUMAN PRESCRIPTION DRUG LABEL	1
Sentralopram AM-10	Physician Therapeutics LLC \| Aurobindo Pharma Limited \| H.J. Harkins Company, Inc. \| Targeted Medical Pharma Inc.	2011-08-01	HUMAN PRESCRIPTION DRUG LABEL	9
Citalopram - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2010-01-20	HUMAN PRESCRIPTION DRUG LABEL	2